drugset
drugset / Trial / NCT02176655

Pilot Study of VVD-101 for the Treatment of Delayed Alcohol-Induced Headaches

NCT02176655 ↗

Phase 2 Completed 31 enrolled Cady, Roger, M.D. Vivid Pharma Inc. · collab
RandomizedCrossoverTriple-blindTreatment

Summary

This study proposes to compare the efficacy of sumatriptan and aspirin to placebo as an acute abortive treatment for delayed alcohol induced headache in adult subjects.

Timeline

Start
2014-07
Primary completion
2016-01
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aspirin Small molecule 325 mg —
Comparator Sumatriptan Unknown 12.5 mg —

Indications

alcohol-induced mental disorder